LYMPHOMA MODELS FOR B-CELL ACTIVATION AND TOLERANCE .3. CELL-CYCLE DEPENDENCE FOR NEGATIVE SIGNALING OF WEHI-231 B LYMPHOMA-CELLS BY ANTI-MU

被引：137
|
作者：
SCOTT, DW [1 ]
LIVNAT, D [1 ]
PENNELL, CA [1 ]
KENG, P [1 ]
机构：
[1] UNIV ROCHESTER,CTR CANC,EXPTL THERAPEUT UNIT,ROCHESTER,NY 14642
来源：
JOURNAL OF EXPERIMENTAL MEDICINE | 1986年 / 164卷 / 01期
关键词：
D O I：
10.1084/jem.164.1.156
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：156 / 164
页数：9
相关论文
共 50 条
  • [31] T-cell activation induced by anti-CD3 × anti-B-cell lymphoma monoclonal antibody is enhanced by pretreatment of lymphoma cells with soluble CD40 ligand
    James E. Wooldridge
    Chris E. Dahle
    George J. Weiner
    Cancer Immunology, Immunotherapy, 1997, 45 : 174 - 179
  • [32] LYMPHOMA MODELS FOR B-CELL ACTIVATION AND TOLERANCE .9. EFFICIENT REVERSAL OF ANTI-IG-MEDIATED GROWTH-INHIBITION BY AN ACTIVATED TH2 CLONE
    ALESMARTINEZ, JE
    SILVER, L
    LOCASCIO, N
    SCOTT, DW
    CELLULAR IMMUNOLOGY, 1991, 135 (02) : 402 - 409
  • [33] Critical role of PI3K signaling for NF-κB-dependent survival in a subset of activated B-cell-like diffuse large B-cell lymphoma cells
    Kloo, Bernhard
    Nagel, Daniel
    Pfeifer, Matthias
    Grau, Michael
    Duewel, Michael
    Vincendeau, Michelle
    Doerken, Bernd
    Lenz, Peter
    Lenz, Georg
    Krappmann, Daniel
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2011, 108 (01) : 272 - 277
  • [34] B-cell receptor-mediated NFATc1 activation induces IL-10/STAT3/PD-L1 signaling in diffuse large B-cell lymphoma
    Li, Li
    Zhang, Jun
    Chen, Juan
    Xu-Monette, Zijun Y.
    Miao, Yi
    Xiao, Min
    Young, Ken H.
    Wang, Sa
    Medeiros, L. Jeffrey
    Wang, Michael
    Ford, Richard J.
    Pham, Lan V.
    BLOOD, 2018, 132 (17) : 1805 - 1817
  • [35] T-cell activation induced by anti-CD3 x anti-B-cell lymphoma monoclonal antibody is enhanced by pretreatment of lymphoma cells with soluble CD40 ligand
    Wooldridge, JE
    Dahle, CE
    Weiner, GJ
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 1997, 45 (3-4) : 174 - 179
  • [36] INVOLVEMENT OF CD5 IN T(H)1 AND T(H)2 CONTACT-MEDIATED RESCUE OF ANTI-MU AND IONOMYCIN INDUCED GROWTH-INHIBITION IN A B-CELL LYMPHOMA
    MUTHUKKUMAR, S
    BONDADA, S
    INTERNATIONAL IMMUNOLOGY, 1995, 7 (02) : 305 - 315
  • [37] Activation of the STAT3 Signaling Pathway Is Associated With Poor Survival in Diffuse Large B-Cell Lymphoma Treated With R-CHOP
    Huang, Xin
    Meng, Bin
    Iqbal, Javeed
    Ding, B. Belinda
    Perry, Anamarija M.
    Cao, Wenfeng
    Smith, Lynette M.
    Bi, Chengfeng
    Jiang, Chunsun
    Greiner, Timothy C.
    Weisenburger, Dennis D.
    Rimsza, Lisa
    Rosenwald, Andreas
    Ott, German
    Delabie, Jan
    Campo, Elias
    Braziel, Rita M.
    Gascoyne, Randy D.
    Cook, James R.
    Tubbs, Raymond R.
    Jaffe, Elaine S.
    Armitage, James O.
    Vose, Julie M.
    Staudt, Louis M.
    McKeithan, Timothy W.
    Chan, Wing C.
    Ye, B. Hilda
    Fu, Kai
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (36) : 4520 - 4528
  • [38] Anti-CD79b/CD3 bispecific antibody combined with CAR19-T cells for B-cell lymphoma treatment
    Wei-Wei Zheng
    Hang Zhou
    Ping Li
    Shi-Guang Ye
    Tuersunayi Abudureheman
    Li-Ting Yang
    Kai Qing
    Ai-Bin Liang
    Kai-Ming Chen
    Cai-Wen Duan
    Cancer Immunology, Immunotherapy, 2023, 72 : 3739 - 3753
  • [39] Anti-CD79b/CD3 bispecific antibody combined with CAR19-T cells for B-cell lymphoma treatment
    Zheng, Wei-Wei
    Zhou, Hang
    Li, Ping
    Ye, Shi-Guang
    Abudureheman, Tuersunayi
    Yang, Li-Ting
    Qing, Kai
    Liang, Ai-Bin
    Chen, Kai-Ming
    Duan, Cai-Wen
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2023, 72 (11) : 3739 - 3753
  • [40] LYMPHOMA MODELS FOR B-CELL ACTIVATION AND TOLERANCE .8. CROSS-DESENSITIZATION BY SIGM AND SIGD AND ITS EFFECTS ON GROWTH-REGULATION BY ANTIISOTYPE ANTIBODIES
    ALESMARTINEZ, JE
    WARNER, GL
    SCOTT, DW
    CELLULAR IMMUNOLOGY, 1990, 127 (02) : 527 - 534
12345